6-(5-Chloropyridin-2-yl)-5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione, 98%, 100mg

4'-Carboxybenzo-15-crown 5-Ether>98.0%(GC)(T)1g

1,2-Dimethylnaphthalene>95.0%(GC)5g

2-((S)-N-(2,3-Dihydro-1H-inden-2-yl)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic acid hydrochloride, 97%, 5g

9-([1,1'-Biphenyl]-4-yl)-10-bromoanthracene, 95.0%, 25g

Tetraidrofurano, minimo 99,5%, per sintesi, 250 ml, confezione in vetro

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 250mg

5-amino-6-(dimethylamino)-1,3-dihydro-2H-benzimidazol-2-one dihydrochloride hydrate, 95.0%, 5g

tert-Butyl (R)-3-(cyanomethyl)piperazine-1-carboxylate, 97%, 100mg

5-Bromonicotinic acid, 98.0%, 10g

Methyl 4'-(hydroxymethyl)-[1,1'-biphenyl]-4-carboxylate, 97%, 100mg

METHYL 5-CHLORO-4-NITROTHIOPHENE-2-CARBOXYLATE, 95.0%, 25g

(S)-tert-Butyl 1,4-oxazepan-6-ylcarbamate, 97%, 500mg